Abstract:OBJECTIVE:To analyze the feasibility of using vascular plaque quantification (VPQ) to evaluate carotid atherosclerotic plaques and to observe the effect of statins on carotid atherosclerotic plaques. METHODS:Patients with carotid plaques from January 2016 to September 2018 in Peking University First Hospital Neurology Department were recruited and underwent three-dimonsional ultrasound (3DUS). Their gray scale median (GSM) and other parameters of carotid plaques were measured with VPQ. The patients were divided into low GSM group (GSM < 40) and high GSM group (GSM≥40). The clinical characteristics and plaque characteristics of the patients in the two groups were compared to analyze the stability of plaques. According to whether taking statins or not, the patients were further divided into statin group and non-statin group, plaque GSM and other parameters of their carotid plaques were measured and the changes of carotid plaques at the end of 3 months and 2 years were observed. RESULTS:A total of 120 patients were enrolled, including 79 males and 41 females, with an average age of (65.39±9.11) years. The patients were divided into low GSM group (31 cases) (GSM < 40) and high GSM group (89 cases) (GSM≥40). The stenosis of the lumen in the low GSM group was more severe (the area stenosis rate was 41.32%±21.37% vs. 29.79%±17.16%, P < 0.05). The nor-malized wall index (NWI) of plaque in low GSM group was significantly higher than that in high GSM group (0.61 ±0.14 vs. 0.52±0.12, P < 0.01). A total of 77 patients, including 51 males and 26 females, aged (64.96±9.58) years, were enrolled to observe the statin effects on carotid plaque. They were divided into statin group (n=56) and non-statin group (n=21) according to whether taking statins or not. At the baseline and 3-month follow-up, there were no significant differences in carotid plaque volume, area, degree of luminal stenosis and GSM between the two groups (P>0.05). At the end of the 2-year follow-up, GSM increased in the statin group [median 10.00 (2.00, 28.00)] but decreased in the non-statin group [median －7.00 (－11.00, 5.50)], with a statistically significant difference between the two groups (P < 0.01). There was no significant increase in carotid plaque volume in the statin group, while there was a slight increase in the non-statin group, but there was no significant difference between the two groups [median increase in plaque volume was 0.00 (－30.00, 40.00) mm3 in the statin group and 30.00 (10.00, 70.00) mm3 in the non-statin group, P>0.05]. CONCLUSION:The VPQ technology of 3DUS can be used to evaluate carotid atherosclerotic plaques. Patients with low GSM (GSM < 40) have more severe vascular stenosis and higher normalized wall index. VPQ technology can also be used to observe the effect of statins on carotid plaque, the GSM of plaques increase in patients who are taking moderate-intensity statin treatment for two years.

Stabilization and Regression of Carotid Atherosclerosis among Patients Receiving Eliminating Phlegm and Removing Stasis Formula-tion Investigated by Ultrasound with Grey scale Median:a Single center Trail

Associations among Carotid Plaque Progression, Cerebrovascular/ Cardiovascular Diseases and LDL-C/non-HDL-C Goal Achievement in Diabetic Patients: A Retrospective Cohort Study

Evaluation of the effect of atorvastatin on neovascularization in the carotid atherosclerotic plaques by contrast enhanced ultrasonography

Assessment of carotid atherosclerotic stenosis with ultrasonography versus CT angiography

Atorvastatin Calcium for Carotid Atherosclerotic Plaques:Evaluation with Contrast-Enhanced Ultrasonography

Investigation on effect of low-dosage Atorvastatin plus Asprin on carotid atherosclerosis plaque and inflammation in elderly patients

Effects on simvastatin on the atherosclerotic plaques of carotid artery in elderly patients with normal lipidenia level

Clinical effects of grape seed proanthocyanidin extract combined with atorvastatin on elderly carotid atherosclerosis

Observation on Efficacy of Pharmaceutical Treatment of Non-symptomatic Carotid Atherosclerosis with Simvastatin

Clinical study of the effect of Tongxinluo capsule on carotid atherosclerotic instable plaque

Three-dimensional Ultrasound Imaging: an Effective Method to Detect the Effect of Moderate Intensity Statin Treatment in Slowing Carotid Plaque Progression

Beneficial Clinical Effects of Grape Seed Proanthocyanidin Extract on the Progression of Carotid Atherosclerotic Plaques.

[Clinical Cohort Study of Imaging Evaluation and Postoperative Pathology of Carotid Vulnerable Plaque].

Effects of atorvastatin on atherosclerotic plaques in elderly patients with hyperlipoidemia

[Evaluation of Carotid Atherosclerotic Plaques by Vascular Plaque Quantification (VPQ) Technology of Three-Dimensional Ultrasonography].

Combining Ultrasound with Bio-Indicators Reveals Progression of Carotid Stenosis.

Carotid Angioplasty and Stenting and Medicine in Treating Patients with Symptomatic Carotid Artery Stenosis

The Clinical Observation of Statins on Adjuvant Treatment of Carotid Artery Stenosis

Improving effects of rosuvastatin calcium on atherosclerosis and cerebral blood flow dynamics in patients with cerebral infarction

[Clinical Selection of Endovascular Stenting and Carotid Endarterectomy in Treatment of Carotid Artery Stenosis].

Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin